Amaryllidaceae isocarbostyril alkaloids and their derivatives as promising antitumor agents

Translational Oncology

Volumn 1, Issue 1, 2008, Pages 1-13

  Ingrassia, Laurent ^a   Lefranc, Florence ^b,c   Mathieu, Véronique ^c   Darro, Francis ^a   Kiss, Robert ^c  

^a Unibioscreen SA   (Belgium)

^b ERASME HOSPITAL   (Belgium)

^c UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 70350085648     PISSN: None     EISSN: 19365233     Source Type: Journal    
DOI: 10.1593/tlo.08100     Document Type: Article

References (71)

1. Cragg GM, Newman DJ, and Snader KM (1997). Natural products in drug discovery and development. J Nat Prod 60 (1), 52-60.
2. Newman DJ, Cragg GM, and Snader KM (2003). Natural products as sources of new drugs over the period 1981-2002. J Nat Prod 66 (7), 1022-1037.
3. Hartwell JL (1967). Plants used against cancer. A survey. Lloydia 30 (4), 379-436.
4. Weniger B, Italiano L, Beck JP, Bastida J, Bergoñon S, Codina C, Lobstein A, and Anton R (1995). Cytotoxic activity of Amaryllidaceae alkaloids. Planta Med 61 (1), 77-79.
5. Ibn-Ahmed S, Khaldi M, Chrétien F, and Chapleur Y (2004). A short route to enantiomerically pure benzophenanthridone skeleton: synthesis of lactone analogues of narciclasine and lycoricidine. J Org Chem 69 (20), 6722-6731.
6. Ghosal S, Singh S, Kumar Y, and Srivastava S (1989). Isocarbostyril alkaloids from Haemanthus kalbreyeri. Phytochemistry 28 (2), 611-613.
7. Pettit GR, Pettit GR III, Backhaus RA, Boyd MR, and Meerow AW (1993). Antineoplastic agents: 256. Cell growth inhibitory isocarbostyrils from Hymenocallis. J Nat Prod 56 (10), 1682-1687.
8. Ceriotti G (1967). Narciclasine: an antimitotic substance from Narcissus bulbs. Nature 213 (5076), 595-596.
9. Piozzi F, Fuganti C, Mondelli R, and Ceriotti G (1968). Narciclasine and narciprimine. Tetrahedron 24 (11), 1119-1131.
10. Mondon A and Krohn K (1970). Revision der Narciprimin-Struktur. Chem Ber 103 (9), 2729-2743.
11. Piozzi F, Marino L, Fuganti C, and Di Martino A (1969). Occurrence of nonbasic metabolites in Amaryllidaceae. Phytochemistry 8 (9), 1745-1748.
12. Okamoto T, Torii Y, and Isogai Y (1968). Lycoricidinol and lycoricidine, new plant-growth regulators in the bulbs of Lycoris radiata herb. Chem Pharm Bull 16 (9), 1860-1864.
13. Numata A, Takemura T, Ohbayashi H, Katsuno T, Yamamoto K, Sato K, and Kobayashi S (1983). Antifeedants for the larvae of the yellow butterfly, Eurema hecabe mandarina, in Lycoris radiata. Chem Pharm Bull 31 (6), 2146-2149.
14. Pettit GR, Pettit GR III, Backhaus RA, and Boettner FE (1995). Antineoplastic agents: 294. Variations in the formation of pancratistatin and related isocarbostyrils in Hymenocallis littoralis. J Nat Prod 58 (1), 37-43.
15. Pettit GR, Pettit GR III, Groszek G, Backhaus RA, Doubek DL, Barr R, and Meerow AW (1995). Antineoplastic agents: 301. An investigation of the Amaryllidaceae genus Hymenocallis. J Nat Prod 58 (5), 756-759.
16. Pettit GR, Meng Y, Herald DL, Knight JC, and Day JF (2005). Antineoplastic agents: 553. The Texas grasshopper Brachystola magna. J Nat Prod 68 (8), 1256-1258.
17. Fuganti C, Staunton J, and Battersby AR (1971). The biosynthesis of narciclasine. J Chem Soc D: Chem Commun 19, 1154-1155.
18. Fuganti C and Mazza M (1972). The absolute configuration of narciclasine: a biosynthetic approach. J Chem Soc Chem Commun 4, 239.
19. Ghosal S, Lochan R, Ashutosh Kumar Y, and Srivastava RS (1985). Alkaloids of Haemanthus kalbreyeri. Phytochemistry 24 (8), 1825-1828.
20. Ghosal S, Singh SK, and Srivastava RS (1986). Alkaloids of Zephyranthes flava. Phytochemistry 25 (8), 1975-1978.
21. Abou-Donia AH, De Giulio A, Evidente A, Gaber M, Habib AA, Lanzetta R, and Seif El-Din AA (1991). Narciclasine-4-O-β-D-glucopyranoside, a glucosyloxy amidic phenanthridone derivative from Pancratium maritimum. Phytochemistry 30 (10), 3445-3448.
22. Pettit GR, Cragg GM, Singh SB, Duke JA, and Doubek DL (1990). Antineoplastic agents: 162. Zephyranthes candida. J Nat Prod 53 (1), 176-178.
23. Pettit GR and Melody N (2005). Antineoplastic agents: 527. Synthesis of 7- deoxynarcistatin, 7-deoxy-trans-dihydronarcistatin, and trans-dihydronarcistatin 1. J Nat Prod 68 (2), 207-211.
24. Pettit GR, Gaddamidi V, Herald DL, Singh SB, Cragg GM, Schmidt JM, Boettner FE, Williams M, and Sagawa Y (1986). Antineoplastic agents: 120. Pancratium littorale. J Nat Prod 49 (6), 995-1002.
25. Pettit GR, Eastham SA, Melody N, Orr B, Herald DL, McGregor J, Knight JC, Doubek DL, Pettit GR III, Garner LC, et al. (2006). Isolation and structural modification of 7-deoxynarciclasine and 7-deoxy-trans-dihydronarciclasine. J Nat Prod 69 (1), 7-13.
26. Pettit GR, Gaddamidi V, Cragg GM, Herald DL, and Sagawa Y (1984). Isolation and structure of pancratistatin. J Chem Soc Chem Commun 24, 1693-1694.
27. Gabrielsen B, Monath TP, Huggins JW, Kefauver DF, Pettit GR, Groszek G, Hollingshead M, Kirsi JJ, Shannon WM, Schubert EM, et al. (1992). Antiviral (RNA) activity of selected Amaryllidaceae isoquinoline constituents and synthesis of related substances. J Nat Prod 55 (11), 1569-1581.
28. Ouarzane-Amara M, Franetich JF, Mazier D, Pettit GR, Meijer L, Doerig C, and Desportes-Livage I (2001). In vitro activities of two antimitotic compounds, pancratistatin and 7-deoxynarciclasine, against Encephalitozoon intestinalis, a microsporidium causing infections in humans. Antimicrob Agents Chemother 45 (12), 3409-3415.
29. Ghosal S, Datta K, Singh SK, and Kumar Y (1990). Telastaside a stress-related alkaloid-conjugate from Polytela gloriosa, an insect feeding on Amaryllidaceae. J Chem Res 10, 334-335.
30. Kojima K, Mutsuga M, Inoue M, and Ogihara Y (1998). Two alkaloids from Zephyranthes carinata. Phytochemistry 48 (7), 1199-1202.
31. Rinner U and Hudlicky T (2005). Synthesis of Amaryllidaceae constituents-an update. Synlett 3, 365-387.
32. Hudlicky T, Rinner U, Gonzales D, Akgun H, Schilling S, Siengalewicz P, Martinot TA, and Pettit GR (2002). Total synthesis and biological evaluation of Amaryllidaceae alkaloids: narciclasine, ent-7-deoxypancratistatin, regioisomer of 7-deoxypancratistatin, 10b-epi-deoxypancratistatin, and truncated derivatives. J Org Chem 67 (25), 8726-8743.
33. Gibson DT, Hensley M, Yoshioka H, and Mabry TJ (1970). Formation of (+)- cis-2,3-dihydroxy-1-methylcyclohexa-4,6-diene from toluene by Pseudomonas putida. Biochemistry 9 (7), 1626-1630.
34. Hudlicky T and Olivo HF (1992). A short synthesis of (+)-lycoricidine. J Am Chem Soc 114 (24), 9694-9696.
35. Tian X, Hudlicky T, and Königsberger K (1995). First total synthesis of (+)- pancratistatin: an usual set of problems. J Am Chem Soc 117 (12), 3643-3644.
36. Doyle TJ, Hendrix M, VanDerveer D, Javanmard S, and Haseltine JA (1997). Convergent synthesis of (+)-pancratistatin based on intramolecular electrophilic aromatic substitution. Tetrahedron 53 (32), 11153-11170.
37. Trost BM and Pulley SR (1995). Asymmetric synthesis of (+)-pancratistatin. J Am Chem Soc 117 (40), 10143-10144.
38. Rigby JH, Maharoof USM, and Mateo ME (2000). Studies on the narciclasine alkaloids: total synthesis of (+)-narciclasine and (+)-pancratistatin. J Am Chem Soc 122 (28), 6624-6628.
39. Magnus P and Sebhat IK (1998). Application of the β-azidonation reaction to the synthesis of the antitumor alkaloid (+)-pancratistatin. Tetrahedron 54 (51), 15509-15524.
40. Ko H, Kim E, Park JE, Kim D, and Kim S (2004). Total synthesis of pancratistatin relying on the [3,3]-sigmatropic rearrangement. J Org Chem 69 (1), 112-121.
41. Li M, Wu A, and Zhou P (2006). A concise synthesis of (+)-pancratistatin using pinitol as a chiral building block. Tetrahedron Lett 47 (22), 3707-3710.
42. Pettit GR, Melody N, and Herald DL (2001). Antineoplastic agents: 450. Synthesis of (+)-pancratistatin from (+)-narciclasine as relay. J Org Chem 66 (8), 2583-2587.
43. Pettit GR and Melody N (2002). Synthesis of pancratistatin. WIPO patent WO0250023 [June 27].
44. Mondon A and Krohn K (1975). Zur kenntris des narciclasins. Chem Ber 108 (2), 445-463.
45. Pettit GR, Melody N, and Herald DL (2004). Antineoplastic agents: 511. Direct phosphorylation of phenpanstatin and pancratistatin. J Nat Prod 67 (3), 322-327.
46. NCI database. Available at: http://dtp.nci.nih.gov/.
47. Rinner U, Hudlicky T, Gordon H, and Pettit GR (2004). A β-carboline-1-one mimic of the anticancer Amaryllidaceae constituent pancratistatin: synthesis and biological evaluation. Angew Chem Int Ed Engl 43 (40), 5342-5346.
48. Pettit GR, Melody N, Simpson M, Thompson M, Herald DL, and Knight JC (2003). Antineoplastic agents: 500. Narcistatin. J Nat Prod 66 (1), 92-96.
49. Pettit GR, Orr B, and Ducki S (2002). Synthesis of pancratistatin prodrugs. WIPO patent WO02085848[October 31].
50. Pettit GR and Melody N (2006). Pancratistatin cyclic phosphate prodrugs an phenpanstatin cyclic phosphate prodrugs. US Patent US2006128668 [June 15].
51. Pettit GR and Melody N (2004). Narcistatin prodrugs. WIPO patentWO2004052298 [June 24].
52. Pettit GR and Melody N (July 20, 2006). Synthesis of sodium narcistatin and related compounds. WIPO patent WO2006076726.
53. McNulty J, Mao J, Gibe R, Mo R, Wolf S, Pettit GR, Herald DL, and Boyd MR (2001). Studies directed towards the refinement of the pancratistatin cytotoxic pharmacophore. Bioorg Med Chem Lett 11 (2), 169-172.
54. Rinner U, Hillebrenner HL, Adams DR, Hudlicky T, and Pettit GR (2004). Synthesis and biological activity of some structural modifications of pancratistatin. Bioorg Med Chem Lett 14 (11), 2911-2915.
55. Pettit GR, Melody N, O'Sullivan M, Thompson MA, Herald DL, and Coates B (1994). Synthesis of 10b-R-hydroxy-pancratistatin via narciclasine. J Chem Soc Chem Commun 23, 2725-2726.
56. Bi Y, Guo J, Zhang L, and Wong Y (2003). Changes in some enzymes of microbodies and plastid development in excised radish cotyledons: effect of narciclasine. J Plant Physiol 160 (9), 1041-1049.
57. Van Doorn WG, Sinz A, and Tomassen MM (2004). Daffodil flowers delay senescence in cut Iris flowers. Phytochemistry 65 (5), 571-577.
58. Jimenez A, Santos A, Alonso G, and Vazquez D (1976). Inhibitors of protein synthesis in eukaryotic cells. Comparative effects of some Amaryllidaceae alkaloids. Biochim Biophys Acta 425 (3), 342-348.
59. 3H]narciclasine to eukaryotic ribosomes. A study on a structure-activity relationship. Biochim Biophys Acta 518 (1), 95-103.
60. Dall'Acqua F and Rodighiero C (1977). Investigations on the mechanism of action of narciclasine. Farmaco 32 (1), 67-75.
61. McLachlan A, Kekre N, McNulty J, and Pandey S (2005). Pancratistatin: a natural anti-cancer compound that targets mitochondria specifically in cancer cells to induce apoptosis. Apoptosis 10 (3), 619-630.
62. Griffin C, Sharda N, Sood D, Nair J, McNulty J, and Pandey S (2007). Selective cytotoxicity of pancratistatin-related natural Amaryllidaceae alkaloids: evaluation of the activity of two new compounds. Cancer Cell Int 7, 10.
63. Pandey S, Kekre N, Naderi J, and McNulty J (2005). Induction of apoptotic cell death specifically in rat and human cancer cells by pancratistatin. Artif Cells Blood Substit Immobil Biotechnol 33 (3), 279-295.
64. Kekre N, Griffin C, McNulty J, and Pandey S (2005). Pancratistatin causes early activation of caspase-3 and the flipping of phosphatidyl serine followed by rapid apoptosis specifically in human lymphoma cells. Cancer Chemother Pharmacol 56 (1), 29-38.
65. McNulty J, Larichev V, and Pandey S (2005). A synthesis of 3-deoxydihydrolycoricidine: refinement of a structurally minimum pancratistatin pharmacophore. Bioorg Med Chem Lett 15 (23), 5315-5318.
66. Dumont P, Ingrassia L, Rouzeau S, Ribaucour F, Thomas S, Roland I, Darro F, Lefranc F, and Kiss R (2007). The Amaryllidaceae isocarbostyril narciclasine induces apoptosis by activation of the death receptor and/or mitochondrial pathways in cancer cells but not in normal fibroblasts. Neoplasia 9 (9), 766-776.
67. Zhang XD, Nguyen T, Thomas WD, Sanders JE, and Hersey P (2000). Mechanisms of resistance of normal cells to TRAIL induced apoptosis vary between different cell types. FEBS Lett 482 (3), 193-199.
68. Zhu H, Ling W, Hu B, Su Y, Qiu S, Xiao W, and Qi Y (2006). Adenovirus E1A reverses the resistance of normal primary human lung fibroblast cells to TRAIL through DR5 upregulation and caspase 8-dependent pathway. Cancer Biol Ther 5 (2), 180-188.
69. Tanaka T, Yoshimi M, Maeyama T, Hagimoto N, Kuwano K, and Hara N (2002). Resistance to Fas-mediated apoptosis in human lung fibroblast. Eur Respir J 20 (5), 359-368.
70. Yui S, Mikami M, Mikami Y, Sashida Y, and Yamazaki M (2001). Inhibition effect of Amaryllidaceae alkaloids, lycorine and lycoricidinol on macrophage TNF-alpha production. Yakugaku Zasshi 121 (2), 167-171.
71. Babbar N and Casero RA Jr (2006). Tumor necrosis factor-alpha increases reactive oxygen species by inducing spermine oxidase in human lung epithelial cells: a potential mechanism for inflammation-induced carcinogenesis. Cancer Res 66 (23), 11125-11130.